Beyond a critical level of iron there is a rapid fall in yield of toxin and porphyrin but growth rate continues to increase. Simultaneously with the fall in porphyrin and toxin production the cytochrome spectrum of the cell becomes strong (Pappenheimer & Hendee 1947) . The suggestion has been made th at diphtheria toxin is a portion of the cytochrome molecule which the cell continues to produce in media containing concentrations of iron suboptimal for cytochrome production. The biological activity of the toxin could then be regarded as due to close resemblance to the protein portion of a vitally important animal enzyme system.
If I have seemed, in the latter half of my contribution to this symposium, to allow myself a generous amount of speculation, it is because, for the present, we lack exact knowledge of intermediary metabolism, knowledge which is a prerequisite for the intelligent application of the Fildes-Woods hypothesis to chemotherapy. If my speculations in the field of peptide chemistry do something to stimulate further study of natural and synthetic peptides they will not have been entirely worthless.
The design of bacterial inhibitors modelled on growth factors
By H. N. R ydon Fildes, in 1940, put forward a plea for 'A rational approach to research in chemo therapy ' in which he advocated research directed towards the preparation of modi fied essential metabolites which should be sufficiently closely related to the essential metabolite on which they were based as to fit the same enzyme, but sufficiently dissimilar as to be themselves devoid of essential metabolic activity. This idea was taken up widely, and fruitfully, but often without due regard to the factors making for true similarity between metabolite and inhibitor; the present paper is an appeal for such a rational approach to chemotherapy to be based on a proper appreciation of the structural factors on which such similarity must be founded.
It must be admitted th at most of the metabolite analogues which have been prepared and tested as a result of the general acceptance of Fildes's idea have proved of little value as practical chemotherapeutic agents. A possible reason for this lack of success lies in the fact th at the analogies between metabolite and inhibitor have been purely 'pictorial' in nature; in general, the inhibitors have simply been made to 'look like' the metabolite. In the author's opinion, Fildes's principle is unlikely to be very fruitful if we continue to confine ourselves to such naive pictorial analogies which are both not enough and too much. Pictorial analogy is not enough because an analogue may look like a metabolite and yet lack the chemical groupings necessary for combination with the appropriate enzyme; it leads us to overemphasize the geometry and underemphasize the chemistry of the molecule. Pictorial analogy is too much, since there may be a great deal in the structure of the metabolite which is not directly concerned in its attachment to the enzyme; it leads us to overload our inhibitors with possibly unnecessary complica tions. In order to model inhibitors more rationally on essential metabolites we must know two things, viz. the structure of the metabolite we are imitating and the precise way in which the metabolite combines with the bacterial enzyme to which it is related as substrate, co-enzyme or product.
The first of these requirements should give us little trouble, since the number of known growth factors we can set out to imitate is now very large; practically, however, success or failure in the chemotherapy of a particular infection may depend on a wise choice in this respect. Regarding the second, however, there is little information available, and experiment is necessary to determine the mode of linkage of the metabolite and enzyme in each specific case; it seems likely, having regard to the ready reversibility of the type of interaction envisaged, th at secondary valence forces (interaction of poles or dipoles; hydrogen bonding; van der Waals forces) rather than co valencies are likely to be involved.
It is suggested th at the mode of linkage between a metabolite and its related enzyme may be determined experimentally by introducing into the metabolite molecule substituents of known electropolar properties and studying the inhibitory (or metabolic) properties of the resulting compounds. To avoid gross differences in permeability properties, the inhibitors studied should be as similar as possible and comparisons should probably be restricted to isomerides. The procedure, then, is to prepare one or more complete series of isomeric substituted metabolites and deter mine their activities as bacterial inhibitors; differences in inhibitory activity may reasonably be ascribed to different affinities for the bacterial enzyme and, by correlating the results with the known polar and steric properties of the substituents, it may be possible to deduce, in some detail, the nature of the combination of the metabolite and its related bacterial enzyme. If we succeed in this, it should then not be too difficult to devise other modifications of the metabolite structure leading to substances having maximal affinity for the enzyme and so maximal inhibitory activity; in this way, conscious design might supplant the empiricism which still largely governs research in chemotherapy to which wre could claim to have a really rational approach.
This new method may be illustrated by some recent work of Sir Paul Fildes and the author (Fildes & Rydon 1947) . A study of all the seven isomeric methyl-indoles as inhibitors of Bad. typhosum showed three of them (the 1-, 2-and indoles) to be devoid of inhibitory activity; the other four inhibited growth by interfering with the conversion of indole into tryptophan, the order of decreasing inhibitory activity being 4-Me> 6-Me> 7-Me> 5-Me. The lack of activity of all those compounds containing methyl groups in the pyrrole ring suggests th at this ring is closely concerned in the combination of indole with the enzyme; any substitution here causes, probably for stereochemical reasons, a complete failure of the modified metabolite to combine with the enzyme. The alternating effect observed in the inhibitory activity of the compounds containing methyl groups in the benzene ring at once suggests that some polar mechanism is operative.
Application of the accepted principles of the electronic theory of organic chemistry (fully described in the original paper) shows th at in the more inhibitory 4-and 6-methyl-indoles structure (A) will contribute more to the resonance hybrid than it does in indole itself, whereas in the less inhibitory 5-and 7-methyl-indoles structure (B) will be more im portant:
I t seems, therefore, th at the combination of indole (and the methyl-indoles) with the bacterial enzyme concerned must be such th at it is favoured by structure (A). The two structures differ notably in their capacity for hydrogen-bonding to an enzyme since, whereas (B) can enter into only one such bond, (A) can enter simultaneously into two:
•enzymeenzym e I t is suggested, therefore, th at the combination of indole with the enzyme involves attachment of the indole molecule, in form (A), by two hydrogen bonds to two side-chains of the enzyme molecule; such double attachment would be stronger than attachment by a single hydrogen bond, and would also result in a rigid anchoring of the indole molecule into position for further reaction. Assuming a tetrahedral angle between the two hydrogen bonds and a hydrogen bond length of 2-9 A, it is easy to show th at the distance (X ++ Y) between the enzyme side-chains is 4-7 A. Considering the uncertainties, this is remarkably close to the 5-1 A spacing postulated in Astbury & Bell's (1941) structure for the a-proteins. Scale models (figure 2) show th at an indole molecule fits nicely into a fold of such a structure by double hydrogen-bonding to two side-chains; moreover, when this occurs, the atom C3, involved in the subsequent reaction with serine to form tryptophan is brought into reasonable reacting distance of the corresponding pair of side-chains in the opposite fold of the adjacent peptide chain. Such con clusions are admittedly speculative, but it is encouraging to find that they lead to so plausible a picture of the details of the combination of indole and its related bacterial enzyme. Further work on substituted indoles as inhibitors of typhosum is being carried out by the author and his co-workers. As a test of the hypothesis substituents of different electropolar character are being introduced into the benzene ring, while more powerfully electron-releasing groups are being intro duced into the 4-position in the hope of obtaining still more inhibitory com pounds.
Similar considerations can be applied to the inhibition of bacterial growth by various substituted p-amino-benzoic acids (Rydon 1947), but lack of time precludes their discussion now. p la n (The b ro k en line from N x are th e projectio n s of 2-9 A h y d ro g en bonds. T he sm all sh ad ed circles in d icate th e positions of th e side-chains p ro jec tin g below th e p ep tid e b ack-bone, w hich is show n d iag ra m m a tic allv b y th e u n b ro k en stra ig h t lines. O nly N l5 C2 an d C3 of th e indole m olecule are show n.) elevation F ig u r e 2. In dole a n d a n a-folded p ro tein . (C ovalent rad ii, th ic k circles, h av e been ta k e n as O'7 A a n d v a n de W aals radii, th in circles, as T 5 A. H y d ro g en ato m s h av e been om itted .) Some a nti-malarial aoents as possible growth-factor antagonists B y F . L. R o s e Technical difficulties associated with the complex life cycle of the malaria parasite constitute a major impediment in studies of its enzyme composition. Yet such studies have been developed to a remarkable extent during recent years by the use of human, avian and monkey species of parasite, working in particular with the erythrocytic phases either in, or free from the host red cells, or in cell extracts, and it has been concluded th at in many important instances, for example, in its utiliza tion of glucose, the metabolism of the organism conforms to a pattern common among living cells. It is not surprising, therefore, th at attempts to explain the mechanism of action of anti-malarial drugs should be based on the concept of the
